These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 27745990)

  • 1. Analogues of DNA minor groove cross-linking agents incorporating aminoCBI, an amino derivative of the duocarmycins: Synthesis, cytotoxicity, and potential as payloads for antibody-drug conjugates.
    Giddens AC; Lee HH; Lu GL; Miller CK; Guo J; Lewis Phillips GD; Pillow TH; Tercel M
    Bioorg Med Chem; 2016 Nov; 24(22):6075-6081. PubMed ID: 27745990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, Synthesis, and Evaluation of Linker-Duocarmycin Payloads: Toward Selection of HER2-Targeting Antibody-Drug Conjugate SYD985.
    Elgersma RC; Coumans RG; Huijbregts T; Menge WM; Joosten JA; Spijker HJ; de Groot FM; van der Lee MM; Ubink R; van den Dobbelsteen DJ; Egging DF; Dokter WH; Verheijden GF; Lemmens JM; Timmers CM; Beusker PH
    Mol Pharm; 2015 Jun; 12(6):1813-35. PubMed ID: 25635711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of molecular dynamics simulations to evaluate the DNA sequence-selectivity of G-A cross-linking PBD-duocarmycin dimers.
    Jackson PJM; Rahman KM; Thurston DE
    Bioorg Med Chem Lett; 2017 Jan; 27(1):102-108. PubMed ID: 27889454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel class of achiral seco-analogs of CC-1065 and the duocarmycins: design, synthesis, DNA binding, and anticancer properties.
    Kupchinsky S; Centioni S; Howard T; Trzupek J; Roller S; Carnahan V; Townes H; Purnell B; Price C; Handl H; Summerville K; Johnson K; Toth J; Hudson S; Kiakos K; Hartley JA; Lee M
    Bioorg Med Chem; 2004 Dec; 12(23):6221-36. PubMed ID: 15519165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA interstrand crosslinking agents: synthesis, DNA interactions, and cytotoxicity of dimeric achiral seco-amino-CBI and conjugates of achiral seco-amino-CBI with pyrrolobenzodiazepine (PBD).
    Purnell B; Sato A; O'kelley A; Price C; Summerville K; Hudson S; O'hare C; Kiakos K; Asao T; Lee M; Hartley JA
    Bioorg Med Chem Lett; 2006 Nov; 16(21):5677-81. PubMed ID: 16919946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis, and evaluation of a novel pyrrolobenzodiazepine DNA-interactive agent with highly efficient cross-linking ability and potent cytotoxicity.
    Gregson SJ; Howard PW; Hartley JA; Brooks NA; Adams LJ; Jenkins TC; Kelland LR; Thurston DE
    J Med Chem; 2001 Mar; 44(5):737-48. PubMed ID: 11262084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel antitumor indolizino[6,7-b]indoles with multiple modes of action: DNA cross-linking and topoisomerase I and II inhibition.
    Chaniyara R; Tala S; Chen CW; Zang X; Kakadiya R; Lin LF; Chen CH; Chien SI; Chou TC; Tsai TH; Lee TC; Shah A; Su TL
    J Med Chem; 2013 Feb; 56(4):1544-63. PubMed ID: 23360284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel class of in vivo active anticancer agents: achiral seco-amino- and seco-hydroxycyclopropylbenz[e]indolone (seco-CBI) analogues of the duocarmycins and CC-1065.
    Sato A; McNulty L; Cox K; Kim S; Scott A; Daniell K; Summerville K; Price C; Hudson S; Kiakos K; Hartley JA; Asao T; Lee M
    J Med Chem; 2005 Jun; 48(11):3903-18. PubMed ID: 15916443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unsymmetrical DNA cross-linking agents: combination of the CBI and PBD pharmacophores.
    Tercel M; Stribbling SM; Sheppard H; Siim BG; Wu K; Pullen SM; Botting KJ; Wilson WR; Denny WA
    J Med Chem; 2003 May; 46(11):2132-51. PubMed ID: 12747786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel analogues of CC-1065 and the duocarmycins for the use in targeted tumour therapies.
    Tietze LF; Krewer B
    Anticancer Agents Med Chem; 2009 Mar; 9(3):304-25. PubMed ID: 19275523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of in Situ Oxazolidine Formation with Highly Synergistic Cytotoxicity and DNA Cross-Linking in Cancer Cells from Combinations of Doxorubicin and Formaldehyde.
    Barthel BL; Mooz EL; Wiener LE; Koch GG; Koch TH
    J Med Chem; 2016 Mar; 59(5):2205-21. PubMed ID: 26881291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Probing cytochrome P450 (CYP) bioactivation with chloromethylindoline bioprecursors derived from the duocarmycin family of compounds.
    Ortuzar N; Karu K; Presa D; Morais GR; Sheldrake HM; Shnyder SD; Barnieh FM; Loadman PM; Patterson LH; Pors K; Searcey M
    Bioorg Med Chem; 2021 Jun; 40():116167. PubMed ID: 33932713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrocyclic pyrrolobenzodiazepine dimers as antibody-drug conjugate payloads.
    Donnell AF; Zhang Y; Stang EM; Wei DD; Tebben AJ; Perez HL; Schroeder GM; Pan C; Rao C; Borzilleri RM; Vite GD; Gangwar S
    Bioorg Med Chem Lett; 2017 Dec; 27(23):5267-5271. PubMed ID: 29102228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural influence of indole C5-N-substitutents on the cytotoxicity of seco-duocarmycin analogs.
    Choi T; Ma E
    Arch Pharm Res; 2011 Mar; 34(3):357-67. PubMed ID: 21547666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of novel DNA cross-linking antitumour agents based on polyazamacrocycles.
    Parker LL; Anderson FM; O'Hare CC; Lacy SM; Bingham JP; Robins DJ; Hartley JA
    Bioorg Med Chem; 2005 Apr; 13(7):2389-95. PubMed ID: 15755641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and biological evaluation of novel non-racemic indole-containing allocolchicinoids.
    Shchegravina ES; Maleev AA; Ignatov SK; Gracheva IA; Stein A; Schmalz HG; Gavryushin AE; Zubareva AA; Svirshchevskaya EV; Fedorov AY
    Eur J Med Chem; 2017 Dec; 141():51-60. PubMed ID: 29028531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of functional analogs of CC-1065 and the duocarmycins incorporating the cross-linking 9a-chloromethyl-1,2,9,9a-tetrahydrocyclopropa[c]benz[e]indol-4-on e (C2BI) alkylation subunit.
    Boger DL; Johnson DS; Palanki MS; Kitos PA; Chang J; Dowell P
    Bioorg Med Chem; 1993 Jul; 1(1):27-38. PubMed ID: 8081835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Short Review on the Synthetic Strategies of Duocarmycin Analogs that are Powerful DNA Alkylating Agents.
    Patil PC; Satam V; Lee M
    Anticancer Agents Med Chem; 2015; 15(5):616-30. PubMed ID: 25511515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Photocontrollable sequence-specific DNA alkylation by a pyrrole-imidazole polyamide seco-CBI conjugate.
    Park S; Bando T; Shinohara K; Nishijima S; Sugiyama H
    Bioconjug Chem; 2011 Feb; 22(2):120-4. PubMed ID: 21192678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SJG-136 (NSC 694501), a novel rationally designed DNA minor groove interstrand cross-linking agent with potent and broad spectrum antitumor activity: part 1: cellular pharmacology, in vitro and initial in vivo antitumor activity.
    Hartley JA; Spanswick VJ; Brooks N; Clingen PH; McHugh PJ; Hochhauser D; Pedley RB; Kelland LR; Alley MC; Schultz R; Hollingshead MG; Schweikart KM; Tomaszewski JE; Sausville EA; Gregson SJ; Howard PW; Thurston DE
    Cancer Res; 2004 Sep; 64(18):6693-9. PubMed ID: 15374986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.